17 Dec 2024
13m

“BioNTech schlägt Moderna - warum?” - Vivendi & London leiden, OSI hat Trump-Profit

Podcast cover

OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

“BioNTech schlägt Moderna - warum?” - Vivendi & London leiden, OSI hat Trump-Profit